Risk factors and the sex differential in coronary artery disease

Epidemiology

Volumn 8, Issue 5, 1997, Pages 584-591

  Price, Jacqueline F ^a   Fowkes, F Gerald R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Coronary artery disease; Risk factors; Sex differential

Indexed keywords

FIBRINOGEN;

ADULT; AGED; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CORONARY DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; SEX FACTORS;

EID: 0030967749     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199709000-00018     Document Type: Review

References (94)

1. Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990;55:330-352.
2. Wilhelmsen L. Epidemiology of coronary heart disease in young women. In: Oliver MF, ed. Coronary Heart Disease in Young Women. Edinburgh: Churchill Livingstone, 1978;3-11.
3. Dawber TR. Incidence of coronary heart disease, stroke and peripheral arterial disease. In: The Framingham Study; the Epidemiology of Atherosclerotic Disease. Cambridge, MA: Harvard University Press, 1980;59-75.
4. Sternby NH. Atherosclerosis in a defined population: an autopsy study in Malmo, Sweden. Acta Microbiol Scand 1968;194(suppl):61-110.
5. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:80-104.
6. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467-1503.
7. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
8. Doll R, Grey R, Hafner B, Peto R. Mortality in relation to smoking: 20 years' observation on female British doctors. BMJ 1980;2:967-971.
9. Doll R, Peto R. Mortality in relation to smoking: 20 years' observation on male British doctors. BMJ 1976;2:1525-1536.
10. Friedman GD, Dales LG, Ury HK. Mortality in middle-aged smokers and nonsmokers. N Engl J Med 1979;300:213-217.
11. Hammond CE. Smoking in relation to the death rates of one million men and women. In: Haenszel W, ed. Epidemiologic Approaches to the Study of Cancer and Other Chronic Diseases. Natl Cancer Inst Monogr 1966;19: 127-204-
12. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetes: a prospective population-based study. Am J Epidemiol 1983;118:489-496.
13. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987;126:629-637.
14. Wingard DL, Cohn BA. Coronary heart disease mortality among women in Alameda County, 1965 to 1973. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. New York: Haymarket-Doyma, 1987;99-105.
15. Higgins M, Keller JB. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh. Ann Epidemiol 1992;2:69-76.
16. Isles CG, Hole DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 1992;339:702-706.
17. Tverdal A, Thelle DS, Stensvold I, Leren P, Bjartveit K. Mortality in relation to smoking history: 13 years' follow-up of 68000 Norwegian men and women 35-49 years. J Clin Epidemiol 1993;46:475-487.
18. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality: 15-year follow-up of middle-aged men and women in Eastern Finland. Circulation 1996;93:1372-1379.
19. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 1986;256:2835-2838.
20. Harris T, Cook EF, Kannel WB, Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older: the Framingham Heart Study. J Am Geriatr Soc 1988;36:1023-1028.
21. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure and sex differences in myocardial infarction. Circulation 1996;93: 450-456.
22. Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute myocardial infarction. Am Heart J 1991;122:438-447.
23. Larson MG. Assessment of cardiovascular risk factors in the elderly: the Framingham Heart Study. Stat Med 1995;14:1745-1756.
24. Janghorbani M, Hedley AJ, Jones RB, Zhianpour M, Gilmour WH. Gender differential in all-cause and cardiovascular disease mortality. Int J Epidemiol 1993;22:1056-1063.
25. Tyroler HA, Heyden S, Bartel A, Cassel J, Cornoni JC, Hames CG, Kleinbaum D. Blood pressure and cholesterol as coronary heart disease risk factors. Arch Intern Med 1971;128:907-914.
26. Stensvold I, Urdal P, Thürmer H, Tverdal A, Lund-Larsen PG, Foss OP. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J 1992;13:1155-1163.
27. Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ 1993;307:1318-1322.
28. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993;153:598-615.
29. Tobacco Advisory Council. Smoking statistics cited in: Wald N, Nicholaides-Bouman A, eds. UK Smoking Statistics. Oxford: Oxford University Press, 1988.
30. Office of Population Censuses and Surveys. General Household Survey, 1992. London: Her Majesty's Stationery Office, 1994.
31. Breeze E, Maidment A, Bennett N, Flatley J, Carey S. Health Survey for England, 1992: a Survey Carried Out by the Social Services Division of OPCS on Behalf of the Department of Health. London: Her Majesty's Stationery Office, 1994.
32. Zachariah PK, Sheps SG, Bailey KR, Wiltgen CM, Moore AG. Age-related characteristics of ambulatory blood pressure load and mean blood pressure in normotensive subjects. JAMA 1991;265:1414-1417.
33. Kannel WB, Dawber TR, McGhee DC. Perspectives on systolic hypertension: the Framingham Study. Circulation 1980;61:1179-1182.
34. Cornoni-Huntley J, Lacroix AZ, Havlick RJ. Race and sex differentials and the impact of hypertension in the United States: the National Health and Nutrition Survey I Epidemiologic Follow-Up Study. Arch Intern Med 1989; 149:780-788.
35. Mann JI, Lewis B, Shepherd J, Winder AF, Fenster S, Rose L, Morgan B. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence and detection in Britain. BMJ 1988;296:1702-1706.
36. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age: a report based on the Framingham data. Arch Intern Med 1993;153:1065-1073.
37. Larsson B, Bengtsson C, Björntorp P, Lapidus L, Sjöström L, Svärdsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen L. Is abdominal fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? Am J Epidemiol 1992;135:266-273.
38. Johnson A. Sex differentials in coronary heart disease: the explanatory role of primary risk factors. J Health Soc Behav 1977;18:46-54.
39. Wingard DL. The sex differential in mortality rates: demographic and behavioral factors. Am J Epidemiol 1982;115:205-216.
40. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol 1983;117:165-172.
41. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI Workshop. Ann Epidemiol 1992;2:161-176.
42. McGill HC, Stern MP. Sex and atherosclerosis. Atherosclerosis Rev 1979; 4:157-242.
43. Isles CG, Hole DJ, Gillis CR, Hawthorne VM, Lever AF. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ 1989;298:920-924.
44. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-390.
45. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol 1992;2:23-28.
46. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein cholesterol as a protective factor against coronary heart disease. Am J Med 1977;62:707-714.
47. Jacobs DR, Melbane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32-47.
48. Gordon DJ. Role of circulating high-density lipoprotein and triglycerides in coronary artery disease: risk and prevention. Endocrinol Metab Clin North Am 1990;19:299-309.
49. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening and myocardial infarction: the Framingham study. Arteriosclerosis 1988;8:207-211.
50. Brunner D, Weisbort J, Meshulam N, Schwartz S, Gross J, Saltz-Rennert H, Altman S, Loehl K, Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol 1987;59:1271-1276.
51. Gordon DJ, Probstfield JL, Garrison RJ. High density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79:8-15.
52. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspectives from the Framingham Study. Am Heart J 1987;114:413-419.
53. Kannel WB. High density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol 1983;52:9b-72b.
54. Hazzard WR. Atherogenesis: why women live longer than men. Geriatrics 1985;40:42-52.
55. Kvist H, Chowdury B, Grangard U. Predictive equations of total and visceral adipose tissue volumes derived from measurements with computed tomography in adult men and women. Am J Clin Nutr 1988;48:1351-1361.
56. Lapidus L, Bengtsson C. Regional obesity as a health hazard in women: a prospective study. Acta Med Scand Suppl 1988;723:53-59.
57. Larsson B. Regional obesity as a health hazard in men: prospective studies. Acta Med Scand Suppl 1988;723:45-51.
58. Thompson CJ, Ryu JE, Craven TE, Kahl FR, Crouse JR. Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb 1991; 11:327-333.
59. Fujioka S, Matsuzawa Y, Tokunaga K, Turui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987;36:54-59.
60. Peiris AN, Hennes MI, Evans DJ, Wilson CR, Lee MB, Kissebah AH. Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med Scand Suppl 1988; 723:179-188.
61. Desprès J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
62. Freedman DS, Jacobsen SJ, Barboriak JJ, Sobocinski KA, Anderson AJ, Kissebah AH, Sasse EA, Gruchow HW. Body fat distribution and male/ female differences in lipids and lipoproteins. Circulation 1990;81:1498-1506.
63. Kannel WB, McGhee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241:2035-2038.
64. Barrett-Connor EL, Cohn BA, Wingard DL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 1991;265:627-631.
65. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as a coronary heart disease risk factor: relationship to other risk factors and predictive value during 9.5 year follow up of the Helsinki Policeman Study Population. Acta Med Scand Suppl 1985;701:38-52.
66. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991;34:356-361.
67. Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H. Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 1991;84:1165-1175.
68. Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Pukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991;11: 80-90.
69. Mykkanen L, Laakso M, Pyörälä K. High plasma insulin levels associated with coronary heart disease in the elderly. Am J Epidemiol 1993;137:1190-1202.
70. Desprès J-P, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957.
71. Welin L, Eriksson H, Larsson B, Ohlson L-O, Svärdsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992;35:766-770.
72. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year study. J Chron Dis 1983;36:371-377.
73. Collins VR, Dowse GK, Zimmet PZ, Tuomilehto J, Alberti KG, Gareeboo H, Nan L. Serum insulin and ECG abnormalities suggesting coronary artery disease in the population of Mauritius and Nauru: cross-sectional and longitudinal associations. J Clin Epidemiol 1993;46:1373-1393.
74. Stout RW. Insulin and atheroma: 20-year perspective. Diabetes Care 1990; 13:631-654.
75. Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin and glycemia in non-diabetic subjects. Am J Med 1986;80: 861-864.
76. Manolio TA, Savage PJ, Burke GL, Lui KA, Wagenknecht LE, Sidney S, Jacobs DR, Roseman JM, Donahue RP, Oberman A. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA Study. Arteriosclerosis 1990;10:430-436.
77. Laakso M, Barrett-Connor E. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 1989;8:665-672.
78. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986;6:123-130.
79. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-1607.
80. Fontbonne A. Insulin: a sex hormone for cardiovascular risk? Circulation 1991;84:1442-1444.
81. Orchard TJ, Becker DJ, Kuller LH, Wagener DK, LaPorte RE, Drash AL. Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk. J Chron Dis 1982;35:123-132.
82. Yki-Jarvinen H. Sex and insulin sensitivity. Metabolism 1984;33:1011-1015.
83. Donahue RP, Orchard TJ, Becker DJ, Kuller LH, Drash AL. Sex differences in the coronary heart disease risk profile: a possible role for insulin: the Beaver County Study. Am J Epidemiol 1987;125:650-657.
84. Bressler P, Bailey S, Saad MF. Insulin resistance and coronary artery disease: the missing link (Abstract). Diabetes 1992;41(suppl):24A.
85. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 1987;258:1183-1186.
86. Hamsten A, Blomback M, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger L. Haemostatic function in myocardial infarction. Br Heart J 1986;55:58-66.
87. Lowe GDO, Lee AJ, Rumley A, Price JF, Fowkes FGR. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997;96:168-173.
88. Meade TW. Epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Bloom AL, Thomas DF, eds. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1987;651-678.
89. Smith FB. Von Willebrand factor, beta-thromboglobulin and platelet activation. In: Fowkes FGR, ed. Epidemiology of Peripheral Vascular Disease. Berlin: Springer-Verlag, 1991;271-283.
90. Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis: early results of the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1992;2:471-480.
91. Meade TW, Vickers MW, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiological characteristics of platelet aggregability. BMJ 1985;290:428-432.
92. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205.
93. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380-385.
94. Sundell IB, Nilsson TK, Ranby M, Hallmans G, Hellsten G. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjo, Sweden. J Clin Epidemiol 1989; 42:719-723.